Anti-inflammatory indomethacin analogs endowed with preferential COX-2 inhibitory activity

被引:20
作者
Amin, Noha H. [1 ]
El-Saadi, Mohammed T. [1 ]
Hefny, Ahmed A. [1 ]
Abdelazeem, Ahmed H. [1 ,2 ]
Elshemy, Heba A. H. [3 ]
Abdellatif, Khaled R. A. [3 ,4 ]
机构
[1] Beni Suef Univ, Dept Med Chem, Fac Pharm, Bani Suwayf 62514, Egypt
[2] Al Rayyan Coll, Coll Med, Al Madinah Al Munawarah 41411, Saudi Arabia
[3] Beni Suef Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Bani Suwayf 62514, Egypt
[4] Ibn Sina Natl Coll Med Studies, Pharmaceut Sci Dept, Jeddah 21418, Saudi Arabia
关键词
anti-inflammatory; celecoxib; cyclooxygenase; docking; indole; indomethacin; Lipinski; molecular; ulcer; BIOLOGICAL EVALUATION; CYCLOOXYGENASE INHIBITION; ULCEROGENIC LIABILITY; DERIVATIVES; DESIGN; INDOLE; DOCKING;
D O I
10.4155/fmc-2018-0224
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Aim: The undeniable indomethacin potency has always suffered serious obstacles such as gastric damage. Continuous attempts to develop potent yet safe indomethacin analogs have never ceased. Results: Herein are new indole derivatives 4a-h and 5a-c, which were synthesized via Fisher indole reaction, evaluated for both their in vivo anti-inflammatory activities using rat paw edema method and their in vitro cyclooxygenase inhibitory activities. Then ulcerogenic liability, physicochemical parameters and molecular docking modeling were performed for the most potent ones. Conclusion: Promising results were obtained, where compound 4f was the best anti-inflammatory agent and preferential COX-2/COX-1 inhibitor (90.5% edema inhibition, selective index = 65.71, ulcer index = 7.3), if compared with indomethacin (86.7% edema inhibition, selective index = 0.079, ulcer index = 20.20).
引用
收藏
页码:2521 / 2535
页数:15
相关论文
共 23 条
[1]
Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents [J].
Abdelazeem, Ahmed H. ;
Gouda, Ahmed M. ;
Omar, Hany A. ;
Tolba, Mai F. .
BIOORGANIC CHEMISTRY, 2014, 57 :132-141
[2]
Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies [J].
Abdellatif, Khaled R. A. ;
Chowdhury, Morshed Alam ;
Dong, Ying ;
Velazquez, Carlos ;
Das, Dipankar ;
Suresh, Mavanur R. ;
Knaus, Edward E. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) :9694-9698
[3]
3-Methyl-2-phenyl-1-substituted-indole derivatives as indomethacin analogs: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents [J].
Abdellatif, Khaled R. A. ;
Lamie, Phoebe F. ;
Omar, Hany A. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (02) :318-324
[4]
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors [J].
Abdellatif, Khaled R. A. ;
Abdelgawad, Mohamed A. ;
Labib, Madlen B. ;
Zidan, Taha H. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) :5787-5791
[5]
Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: Design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies [J].
Abuo-Rahma, Gamal El-Din A. A. ;
Abdel-Aziz, Mohamed ;
Farag, Nahla A. ;
Kaoud, Tamer S. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 83 :398-408
[6]
Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition [J].
Amin, Noha H. ;
Mohammed, Asmaa A. ;
Abdellatif, Khaled R. A. .
FUTURE MEDICINAL CHEMISTRY, 2018, 10 (01) :53-70
[7]
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives [J].
Bakr, Rania B. ;
Azouz, Amany A. ;
Abdellatif, Khaled R. A. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 :6-12
[8]
Synthesis and Biological Evaluation of Orally Active Prodrugs of Indomethacin [J].
Bandgar, Babasaheb P. ;
Sarangdhar, Rajendra Janardan ;
Viswakarma, Santosh ;
Ahamed, Fakrudeen Ali .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (05) :1191-1201
[9]
Celecoxib analogs possessing a N-(4-nitrooxybutyl)piperidin-4-yl or N-(4-nitrooxybutyl)-1,2,3,6-tetrahydropyridin-4-yl nitric oxide donor moiety: Synthesis, biological evaluation and nitric oxide release studies [J].
Chowdhury, Morshed A. ;
Abdellatif, Khaled R. A. ;
Dong, Ying ;
Yu, Gang ;
Huang, Zhangjian ;
Rahman, Moshfiqur ;
Das, Dipankar ;
Velazquez, Carlos A. ;
Suresh, Mavanur R. ;
Knaus, Edward E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (04) :1324-1329
[10]
Diego S., 2007, Discovery Studio Modeling Environment Release 2.1.